SNGX CIK: 812796

Soligenix Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
26.6
FY22:
13.9
FY23:
9.51
FY24:
8.83
FY25:
8.85
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.30
FY22:
0.43
FY23:
0.29
FY24:
0.14
FY25:
0.39
Total assets
Change from FY21 to FY25
millions USD
FY21:
26.9
FY22:
14.3
FY23:
9.80
FY24:
8.97
FY25:
9.24

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
6.29
FY22:
16.5
FY23:
6.15
FY24:
4.85
FY25:
3.70
(negative)
Change from FY21 to FY25
millions USD
FY21:
9.86
FY22:
0.23
FY23:
1.12
FY24:
0
FY25:
0.24
(positive)
Change from FY21 to FY25
millions USD
FY21:
10.7
FY22:
−2.47
FY23:
2.52
FY24:
4.12
FY25:
5.29
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
26.9
FY22:
14.3
FY23:
9.80
FY24:
8.97
FY25:
9.24

All amounts in millions USD Data source:SEC EDGAR